The purpose of this study is to test whether the Relivion® device is safe and helpful in reducing Major Depressive Disorder (MDD) symptoms. An earlier study showed positive results, and the company that developed the device, Neurolief, would like to get marketing clearance in the US and EU using the results of this research.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Robert McClure
Psychiatry - General
Clinical or Medical
Interventional
Alternative or Complementary Medicine
Brain, Head, Nervous System
Chronic Conditions
Genetics and Genetic Disorders
Mental and Emotional Health
Wellness and Lifestyle
Women's Health
21-2836
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
